XOMA Royalty Corp. (XOMA)
25.82
-0.72
(-2.71%)
USD |
NASDAQ |
Dec 12, 13:27
XOMA Royalty Research and Development Expense (TTM): 2.295M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vistagen Therapeutics, Inc. | 49.02M |
| Zevra Therapeutics, Inc. | 16.83M |
| Tango Therapeutics, Inc. | 132.82M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 11.68M |